Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-lowering Ezetimibe and the Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz During Chronic Treatment in Healthy Volunteers With Reference to Intestinal Expression of CYP3A4, UGT1A1, ABCB1 and ABCC2
Clinical trial NCT00810303 · COMPLETED
Trial details
- NCT number
- NCT00810303
- Sponsor
- University Medicine Greifswald
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2009-07-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.